Registry for patients with Thrombotic Thrombocytopenic Purpura in Turkey
Turkey Thrombotic Thrombocytopenic Purpura Disease Registry: National Multicenter Study
Turkish Hematology Association · NCT05950750
This study is collecting information from patients with Thrombotic Thrombocytopenic Purpura in Turkey to see how the disease is treated and how it affects their health over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 960 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Turkish Hematology Association (other) |
| Locations | 1 site (Ankara) |
| Trial ID | NCT05950750 on ClinicalTrials.gov |
What this trial studies
This observational study involves 21 hematology centers across Turkey and aims to recruit 960 patients diagnosed with Thrombotic Thrombocytopenic Purpura (TTP). Participants will be followed for at least one year, during which data on their treatment and health outcomes will be collected through electronic case report forms. The study includes all patients diagnosed with aTTP since January 1, 2015, regardless of their treatment history. The goal is to gather comprehensive data to better understand the disease and its management in the Turkish population.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older diagnosed with aTTP after January 1, 2015, with specific laboratory findings.
Not a fit: Patients who do not meet the inclusion criteria or who refuse to sign the informed consent form will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of TTP and improve patient management strategies.
How similar studies have performed: While observational studies on TTP exist, this specific multicenter registry approach is relatively novel in Turkey.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed as aTTP after 01.01.2015 * Patients with ADAMS13\<10% * Thrombocytopenia (\<100.000) * Coombs (-) * Microangiopathic hemolytic amenia * 18 years and older Exclusion Criteria: \- Patient who does not sign informed consent form
Where this trial is running
Ankara
- Baskent Universtiy Faculty of Medicine — Ankara, Turkey (Türkiye) (RECRUITING)
Study contacts
- Study coordinator: ilker kurkcu
- Email: ilker.kurkcu@sentez-cro.com
- Phone: +905326354515
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: TTP - Thrombotic Thrombocytopenic Purpura, TTP, THD